logo
Σφραγίδα Σφραγίδα

ΛΕΠΤΟΜΕΡΕΙΕΣ ΕΙΔΗΣΕΩΝ

Σπίτι > Ειδήσεις >

Εταιρικές ειδήσεις για Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Εκδηλώσεις
Μας ελάτε σε επαφή με
Ms. Haileeping
86-0554-2796186
Επαφή τώρα

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


τα τελευταία νέα της εταιρείας για Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


τα τελευταία νέα της εταιρείας για Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!

Σφραγίδα
ΛΕΠΤΟΜΕΡΕΙΕΣ ΕΙΔΗΣΕΩΝ
Σπίτι > Ειδήσεις >

Εταιρικές ειδήσεις για-Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


τα τελευταία νέα της εταιρείας για Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


τα τελευταία νέα της εταιρείας για Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection  1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!